Luis Ruiz-Avila
Chief Executive Officer at RUTI IMMUNE & Leukos Biotech SL
Mentor at EIT health´s Mentoring & Coaching Network (MCN). Interim CEO at Leukos Biotech. With a PhD in Molecular Biology from the University of Barcelona and a postgraduate degree in Senior Business Management from IESE Business School.
Luis Ruiz-Avila has a long career as the CEO of several biomedical and biotech start-ups, including ERA Biotech, Advancell, TCD Pharma, Archivel Farma and Spherium Biomed. He is currently CEO of Aquilón Cyl and Leukos Biotech, business adviser to Biointaxis and a mentor in the EIT Health Mentor & Coaching Network.